BIOMAT Database Logo BIOMAT Database Logo

Novel insights into structure and function of factor XIIIa-inhibitor tridegin. 2014

Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Pharmaceutical Chemistry I, Institute of Pharmacy, University of Bonn , Brühler Str. 7, 53119 Bonn, Germany.

The inhibition of the final step in blood coagulation, the factor XIIIa (FXIIIa) catalyzed cross-linking of fibrin monomers, is currently still a challenge in medicinal chemistry. We report synthesis, recombinant expression, disulfide connectivity, and biological activity of tridegin, the sole existing peptide representative displaying inhibitory activity on FXIIIa. Inhibition of the enzyme by this 66-mer cysteine-rich peptide is mediated by its C-terminal sequence, while the N-terminal part comprises structural information and contributes to inhibitor binding. Either of the production strategies examined leads to the formation of different disulfide-bridged isomers indicating the requirement of the correct fold for inhibitory activity. Molecular modeling and docking studies confirm disulfide bond isomer preference with respect to binding to FXIIIa, in turn, the knowledge of the enzyme-inhibitor interactions might bring about comprehensive ideas for the design of a suitable lead structure for addressing FXIIIa.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D012471 Salivary Proteins and Peptides Proteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals. Salivary Gland Protein,Salivary Gland Proteins,Salivary Peptide,Salivary Protein,Salivary Proteins,Salivary Peptides,Gland Protein, Salivary,Peptide, Salivary,Protein, Salivary,Protein, Salivary Gland

Related Publications

Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function.
April 2019, Journal of medicinal chemistry,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Tridegin, a novel peptidic inhibitor of factor XIIIa from the leech, Haementeria ghilianii, enhances fibrinolysis in vitro.
May 1997, Thrombosis and haemostasis,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii.
June 1997, The Biochemical journal,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Synthesis and functional characterization of tridegin and its analogues: inhibitors and substrates of factor XIIIa.
February 2012, ChemMedChem,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Factor VIII - novel insights into form and function.
November 2002, British journal of haematology,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
NMR-Based Structural Characterization of a Two-Disulfide-Bonded Analogue of the FXIIIa Inhibitor Tridegin: New Insights into Structure-Activity Relationships.
January 2021, International journal of molecular sciences,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Structure and function studies of factor XIIIa by x-ray crystallography.
January 1996, Seminars in thrombosis and hemostasis,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
The surprising proton channel: novel insights into its structure and function.
January 2008, Channels (Austin, Tex.),
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9).
December 1998, Biochimica et biophysica acta,
Miriam Böhm, and Charlotte A Bäuml, and Kornelia Hardes, and Torsten Steinmetzer, and Dirk Roeser, and Yvonne Schaub, and Manuel E Than, and Arijit Biswas, and Diana Imhof
Insights into immunophilin structure and function.
January 2011, Current medicinal chemistry,
Copied contents to your clipboard!